Cited by 27Clinical Nutrition and GastroenterologySepsis Diagnosis and TreatmentHyperglycemia and glycemic control in critically ill and hospitalized patients

Glutamine, fish oil and antioxidants in critical illness: MetaPlus trial post hoc safety analysis

Open access
Hofman, Zandrie, Swinkels, Sophie, van Zanten, Arthur R.H.·2016·Annals of Intensive Care

Abstract

BACKGROUND: The role of plasma glutamine, fish oil and antioxidants concentrations in the treatment effect of immune-modulating high-protein versus high-protein enteral nutrition on 6-month mortality in critically ill patients is explored, as unexpected negative outcomes of recent large randomized controlled trials on immune-modulating nutrients have raised questions about safety of these interventions. METHODS: Post hoc analysis of the MetaPlus randomized controlled trial which was performed in a total of 301 medical, surgical and trauma critically ill patients in fourteen European intensive care units. Patients received either immune-modulating (glutamine, fish oil and antioxidant enriched) high-protein (IMHP) or isocaloric high-protein (HP) enteral nutrition. Six-month mortality and baseline, day 4 and day 8 plasma concentrations of glutamine, (eicosapentaenoicacid + decosahexaenoicacid)/long-chain fatty acid plasma level ratio ((epa + dha)/lcf ratio), selenium, vitamin c, vitamin e and zinc were measured. RESULTS: The harmful treatment effect of the IMHP versus HP enteral nutrition on 6-month mortality was only demonstrated in the medical subgroup (HR 2.52, 95% CI 1.36-4.78, P = 0.004). Among medical patients, when corrected for age groups and APACHE-II scores, there were no statistically significant associations between baseline plasma levels and 6-month mortality, except for zinc (HR 1.06, 95% CI 1.00-1.12, P = 0.026). IMHP feeding resulted in statistically significant increase in plasma levels of glutamine, vitamin e, vitamin c and (epa + dha)/lcf ratio from baseline to day 4, while only the change from baseline to day 4 of (epa + dha)/lcf ratio was statistically significant associated with 6-month mortality (HR 1.18, 95% CI 1.02-1.35, P = 0.021) and identified as mediator for the harmful treatment effect of IMHP enteral nutrition among medical ICU patients. CONCLUSION: We hypothesize that the harmful effect of IMHP compared to HP enteral nutrition in a heterogeneous group of critically ill patients is limited to the medical critically ill patients and mediated by an early increase in (epa + dha)/lcf ratio. Trial Registration Dutch Trial Register 26 January 2010 (NTR2181 http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2181 ).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13613-016-0220-y

Cites

26 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Enteral formulae enriched in borage oil and/or omega-3 fatty acids have been administered in patients suffering from ARDS, acute lung injury and sepsis with positive effects regarding length of stay, length of ventilation and even mortality.

    “Enteral formulae enriched in borage oil and/or omega-3 FA have been administered in patients suffering from ARDS, acute lung injury (ALI) and sepsis with positive effects regarding length of stay, length of ventilation and even mortality (239,240,245,248).”

    From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [248]

    Split into 2 atoms — 0 confirmed, 1 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • In the post-hoc analysis of the MetaPlus study, only the change from baseline to day 4 of EPA + DHA/long chain triglyceride (LCT) ratio was statistically significantly associated with six month mortality (hazard ratio 1.18, 95%CI 1.02e1.35,p = 0.021) suggesting a harmful effect of these nutrients in medical ICU patients.

    “In the post-hoc analysis of the MetaPlus study [90], administrating GLN, EPA/DHA and antioxidants to critically ill patients, only the change from baseline to day 4 of EPA þ DHA/long chain triglyceride (LCT) ratio was statistically significantly associated with six month mortality (hazard ratio 1.18, 95%CI 1.02e1.35,p ¼ 0.021) suggesting a harmful effect of these nutrients in medical ICU patients.”

    From ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit (2023) · cites this paper as [90]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • A post hoc analysis of MetaPlus found that the harmful effect of enteral feeding enriched with glutamine, ω-3 fatty acids, and antioxidants on mortality in the medical subgroup was probably mediated by an early increase in (EPA + DHA)/long-chain fatty acid plasma ratio.

    “A post hoc analysis of the MetaPlus trial found that the harmful effect of enteral feeding enriched with glutamine, ω-3 fatty acids, and antioxidants on mortality in the medical subgroup was probably mediated by an early increase in (EPA + DHA)/long-chain fatty acid plasma ratio [63].”

    From Nutrition in Sepsis: A Bench-to-Bedside Review. (2020) · cites this paper as [63]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hofman, Z., Swinkels, S., & van Zanten, A. R. H.
Affiliations
Nutricia Research (Netherlands) (NL)
Venue
Annals of Intensive Care
Publisher
Elsevier BV
Published
2016
Volume
6
Issue
1
Pages
119
ISSN
2110-5820 (ISSN-L)
OpenAlex
W2563482547
Cited by
27
References
26
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 6 · 2022: 1 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 3
FWCI
3.84
Type
journal article
Language
en
Open access
Locations
  • Annals of Intensive Care (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
Keywords
glutamine, fish oil, antioxidants, critical illness, 6-month mortality, eicosapentaenoic acid, docosahexaenoic acid, long-chain fatty acids, selenium, vitamin C, vitamin E, zinc, plasma biomarkers, treatment safety, medical ICU patients

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review